Bioatla Stock Investor Sentiment

BCAB Stock  USD 0.47  0.01  2.17%   
About 59% of Bioatla's investor base is looking to short. The analysis of the overall investor sentiment regarding Bioatla suggests that many traders are alarmed. The current market sentiment, together with Bioatla's historical and current headlines, can help investors time the market. In addition, many technical investors use Bioatla stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at globenewswire.com         
BioAtla Highlighted Clinical Program and Pipeline Updates at Virtual RD Day
Macroaxis News: globenewswire.com
over six months ago at finance.yahoo.com         
BioAtla Granted FDA Fast Track Designation for Ozuriftamab Vedotin for Treatment of Patients with Re...
Yahoo News
over six months ago at seekingalpha.com         
FDA grants fast track status to BioAltas ozuriftamab vedotin
seekingalpha News
over six months ago at simplywall.st         
Were A Little Worried About BioAtlas Cash Burn Rate
Simply Wall St News at Macroaxis
over six months ago at www.macroaxis.com         
Disposition of 555 shares by Sievers Eric of Bioatla at 3.37 subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
3 Penny Stocks With 735 percent Average Upside, According to Wall Street - 247 Wall St.
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Disposition of 1791 shares by Scott Smith of Bioatla at 3.0 subject to Rule 16b-3
Macroaxis News
over six months ago at finance.yahoo.com         
Insider Traders Lose US67k As BioAtla Drops
Yahoo News
over six months ago at www.macroaxis.com         
Disposition of 572 shares by Sievers Eric of Bioatla at 1.37 subject to Rule 16b-3
Macroaxis News
over six months ago at benzinga.com         
BioAtla to Host Virtual RD Day on Clinical Program and Pipeline Updates on July 25, 2024
benzinga news
over six months ago at finance.yahoo.com         
BioAtla to Host Virtual RD Day on Clinical Program and Pipeline Updates on July 25, 2024
Yahoo News
over six months ago at www.macroaxis.com         
Acquisition by Moran Susan of 16500 shares of Bioatla subject to Rule 16b-3
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 657 shares by Sievers Eric of Bioatla at 1.92 subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Investigation for Investors in BioAtla, Inc. over potential Wrongdoing announced - openPR
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Disposition of 572 shares by Sievers Eric of Bioatla at 1.51 subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Bioatla that are available to investors today. That information is available publicly through Bioatla media outlets and privately through word of mouth or via Bioatla internal channels. However, regardless of the origin, that massive amount of Bioatla data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bioatla news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bioatla relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bioatla's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bioatla alpha.

Bioatla Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Bioatla Stock analysis

When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios